In this week's episode, we’ll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival prediction models to help guide management of patients with chronic myelomonocytic leukemia.
Featured Articles:
View all episodes
By American Society of Hematology
4.1
4848 ratings
In this week's episode, we’ll learn more about how exogenous CD19 stimulation affects CAR T-cell persistence in B-cell acute lymphoblastic leukemia treated with CD19 CAR T-cell therapy; new algorithms that incorporate sequential rapid immune-assays, intended to improve diagnosis of heparin-induced thrombocytopenia, and resource-adaptive survival prediction models to help guide management of patients with chronic myelomonocytic leukemia.
Featured Articles:
140 Listeners
324 Listeners
27 Listeners
507 Listeners
87 Listeners
1,120 Listeners
2 Listeners
196 Listeners
362 Listeners
2 Listeners
1 Listeners
29 Listeners
181 Listeners
48 Listeners
3 Listeners